Skip to main content
. 2011 Oct 2;48(4):257–273. doi: 10.1007/s00592-011-0333-6

Fig. 3.

Fig. 3

Therapy strategies challenging gut microbes. The discovery of the role of intestinal microbiota on the control of metabolic diseases opens numerous therapeutic strategies such as prebiotics, probiotics, and immune modulation. It also allows the generation of biomarker strategies to set predictive profiles, to classify and to stratify the patients and the corresponding metabolic and cardiovascular diseases